Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 3/20 | 0.63 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.63 |
| ▸ | IAPP | P10997 | 3/20 | 0.63 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.63 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.63 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.63 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.63 |
| ▸ | PPARG | P37231 | 1/20 | 0.63 |
| ▸ | PPARA | Q07869 | 1/20 | 0.63 |
| ▸ | EP300 | Q09472 | 1/20 | 0.63 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.63 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.63 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.63 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.62 |
| ▸ | TYR | P14679 | 2/20 | 0.61 |
| ▸ | ELANE | P08246 | 2/20 | 0.56 |
| ▸ | CTSG | P08311 | 2/20 | 0.56 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11684136 | 1.00 | BID (0.63) | BIDMCL1IAPPBCL2L1BAK1 | |
| SCHEMBL6471772 | 1.00 | BID (0.63) | BIDMCL1IAPPBCL2L1BAK1 | |
| SCHEMBL5586819 | 1.00 | BID (0.63) | BIDMCL1IAPPBCL2L1BAK1 | |
| SCHEMBL11041823 | 1.00 | BID (0.63) | BIDMCL1IAPPBCL2L1BAK1 | |
| SCHEMBL9188752 | 1.00 | BID (0.63) | BIDMCL1IAPPBCL2L1BAK1 | |
| SCHEMBL9739269 | 1.00 | BID (0.63) | BIDMCL1IAPPBCL2L1BAK1 | |
| SCHEMBL5320034 | 1.00 | BID (0.63) | BIDMCL1IAPPBCL2L1BAK1 | |
| SCHEMBL1614566 | 1.00 | BID (0.63) | BIDMCL1IAPPBCL2L1BAK1 | |
| SCHEMBL1481822 | 1.00 | BID (0.63) | BIDMCL1IAPPBCL2L1BAK1 | |
| SCHEMBL1207097 | 1.00 | BID (0.63) | BIDMCL1IAPPBCL2L1BAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3274322-B1 | STABLE COMPOSITIONS FOR PREVENTION / PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | THE UNIV OF MISSISSIPPI (US) | 2024-08-14 | — | — | EP | claimed |
| US-20240100195-A1 | PATCHES COMPRISING URUSHIOL, TEST PANELS COMPRISING THE SAME, AND METHODS OF USING THE SAME | HAPTEN SCIENCES INC (US) | 2024-03-28 | — | — | US | claimed |
| US-11666667-B2 | Patches comprising urushiol, test panels comprising the same, and methods of using the same | HAPTEN SCIENCES, INC. (US) | 2023-06-06 | — | — | US | claimed |
| US-20200405886-A1 | PATCHES COMPRISING URUSHIOL, TEST PANELS COMPRISING THE SAME, AND METHODS OF USING THE SAME | HAPTEN SCIENCES, INC. | 2020-12-31 | — | — | US | claimed |
| WO-2019160942-A1 | PATCHES COMPRISING URUSHIOL, TEST PANELS COMPRISING THE SAME, AND METHODS OF USING THE SAME | HAMANN CURT (US) | 2019-08-22 | — | — | WO | claimed |
| WO-2018219368-A1 | ORGANIC METHOD FOR ENHANCING CONVENTIONAL JET FUEL AND BIO JET FUEL WITH EMISSIONS REDUCTION | 3-102-735874 SOCIEDAD DE RESPONSABILIDAD LIMITADA (CR) | 2018-12-06 | — | — | WO | claimed |
| WO-2017180769-A1 | SMALL MOLECULES FOR IMMUNOGENIC TREATMENT OF CANCER | CAPTEN THERAPEUTICS INC. (US) | 2017-10-19 | — | — | WO | claimed |
| EP-3017048-A2 | FC COUPLED COMPOSITIONS AND METHODS OF THEIR USE | University of Maryland, College Park (US) | 2016-05-11 | — | — | EP | claimed |
| CN-102831947-B | Conductive-polymer solution, conductive coating, capacitor and manufacture method thereof | SHIN-ETSU POLYMER CO., LTD. (JP) | 2016-01-13 | — | — | CN | claimed |
| US-20150202176-A1 | Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis | THE UNIVERSITY OF MISSISSIPPI | 2015-07-23 | — | — | US | claimed |
| CN-101609725-A | Nano conductive extract | YOULIANG CHENG (CN) | 2009-12-23 | — | — | CN | claimed |
| WO-2009146131-A2 | COMPOSITIONS FOR PREVENTION/PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | THE UNIVERSITY OF MISSISSIPPI (US) | 2009-12-03 | — | — | WO | claimed |
| US-20060147341-A1 | Article and method for detecting skin irritants | JAHNGEN EDWIN G | 2006-07-06 | — | — | US | claimed |
| US-6355691-B1 | Urushiol therapy of transitional cell carcinoma of the bladder | GOODMAN TOBIAS M (US) | 2002-03-12 | — | — | US | claimed |
| WO-1995026980-A2 | HAPTENATED PEPTIDES AND USES THEREOF | IMMULOGIC PHARMACEUTICAL CORPORATION (US) | 1995-10-12 | — | — | WO | claimed |
| EP-0180110-B1 | PROCESS FOR SEPARATING ARSENIC FROM ACID SOLUTIONS CONTAINING IT | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1988-09-07 | — | — | EP | claimed |
| US-4701311-A | EXTRACTION WITH POLYHYDROXYBENZENES IN ORGANIC DILUENTS | CONSIGLIO NAZIONALE DELLE RICHERCHE (IT) | 1987-10-20 | — | — | US | claimed |
| EP-0180110-A1 | Process for separating arsenic from acid solutions containing it | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1986-05-07 | — | — | EP | claimed |
| US-4428965-A | Tolerizing and desensitizing compounds, compositions and methods of treatment against dermatological conditions caused by allergens from plants and trees of the Anacardiaceae and Ginkgoaceae families | THE UNIVERSITY OF MISSISSIPPI (US) | 1984-01-31 | — | — | US | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150202176-A1 | Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis | UGT1A3, IL33, ITCH | BID 851/4885MCL1 3088/4885IAPP 2807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.